JAIME WALL: Open Payments
NPI 1891186912 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,562 in 121 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $2,614 · 2025 $3,562
Food & beverage: $2,338Long term medical supply or device loan: $1,082Education: $142
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,229 |
| AstraZeneca Pharmaceuticals LP | 12 | $405 |
| Gilead Sciences, Inc. | 14 | $404 |
| Janssen Biotech, Inc. | 14 | $262 |
| Merck Sharp & Dohme LLC | 6 | $134 |
| Eisai Inc. | 6 | $117 |
| Astellas Pharma US Inc | 5 | $117 |
| Lilly USA, LLC | 7 | $114 |
| PFIZER INC. | 4 | $78 |
| Legend Biotech USA Inc. | 3 | $77 |
Products named: KISQALI, Trodelvy, ENHERTU, CARVYKTI, KEYTRUDA, Lenvima, Vyloy, VERZENIO.
Industry payments across TN — which companies pay providers there.
